WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.
Dutch experts on climate change adaptation join forces Fourteen Dutch knowledge institutes have joined forces to provide practical, demand-driven policy advice based on climate change adaptation.
Substances of very high concern hamper recycling Substances of very high concern (SVHC) can hamper the safe recycling of waste streams in the Netherlands. These substances occur in a wide range of waste streams.
Chemical legislation REACHes out to bio-based economy European REACH regulation on chemicals can provide benefits to companies that make or import bio-based substances.
Greenhouse Emission model suited for the authorisation of plant protection products Residues of plant protection products used in greenhouses may enter surface water upon discharge of nutrient solution and affect surface water organisms.
Drinking water protection files are steadily progressing Local and provincial authorities, drinking water supply companies and water resource managers authority are making progress with the assessment of the current and future risks for the quality of ex
New bacterium in ticks Last year, a man was treated at the Amsterdam Academic Medical Centre (AMC) after being bitten by a tick and becoming infected with a strain of the Borrelia bacterium not previously encountered in
Regional differences in testing rates underestimate incidence of LGV epidemic Until 2003, Lymphogranuloma venereum (LGV), an aggressive form of chlamydia, was considered to be a rare tropical disease, endemic to Africa, Asia and the Caribbean.